PLAT and Cerebral ischemia: Intravenous recombinant tissue plasminogen activator (tPA) remains the only specific pharmacological therapy for cerebral ischemia, but the narrow time window (within 4.5 h) of thrombolytic therapy and risk of hemorrhagic transformation limit its use.4, 5, 6